3P Biopharmaceuticals celebrates its 15th anniversary with Juan Carlos Unzué.

3P Biopharmaceuticals, a Navarre company founded in 2007, met with 370 employees in an exciting and joyful event looking back over its 15 years of trajectory.

[Noáin, Spain, July 29, 2022] 3P Biopharmaceuticals (3P), a leading organization specializing in cGMP process development and biologics manufacturing (CDMO) celebrates the 1st event of its 15th anniversary with employees and the ex-football player: Juan Carlos Unzué.

Exclusive guests include Amit Karna, president of 3P and partner of Keensight Capital (French Investors who specialize in Health and Technology), and Juan Carlos Unzué, ex-football player and ex-trainer from Navarre, currently fighting against ALS.

A disease rings in the 3P collective since the company is dedicated to developing and manufacturing drugs for treating diseases of social impact and rare diseases such as ALS. Taking advantage of the event, the company donated significantly to the Navarre association ANELA, with which Juan Carlos Unzué is collaborating.

Dámaso Molero, CEO of 3P, took the opportunity to evaluate the company’s development, thanking all those who have trusted in the company since the beginning: “It is incredible how after 15 years of history we have advanced by leaps and bounds, positioning the company as a reference in the biotechnology sector and at an international level, especially in Europe We started absolutely from scratch, and today we are present in 20 countries with almost 400 people, with a profitable and continuously growing business.”

For his part, Amit Karna, President of 3P, rounded off the opening speeches by highlighting the company’s strength: “3P Biopharmaceuticals offers a comprehensive service as a partner for the production of biologic drugs. The services it offers as a CDMO make it a reference for others. As employees, you are lucky to be at a key moment in the company’s history.”
The event was full of great surprises for the employees, with the company wanting to thank employees who have been part of the company for more than ten years for their commitment and dedication. At the same time, several other employees were honored for making their corporate values a reality that identifies them as 3P (People, Passion, and Purpose).

Juan Carlos Unzué ended the event with a motivational speech sharing his life experience with everyone. He sent a clear request to conclude the event: “I request that when a defeat and a bad day appear, and you have the feeling that you can’t go on any longer, remember me. Not as something sad, as I was telling you before. I played football four days ago, two days ago, I was part of a staff, and today I am in a wheelchair. Let this serve you as something positive. Remember that you are healthy and you can work on something you like. You are privileged,” he stressed.

The company started with only one employee (the current CEO Dámaso Molero). Today’s invoices are 35 million euros, with an expectation of 40 million in sales by the end of the year.
Dámaso Molero started in a rented office of CEIN and today occupies three buildings in the Noain industrial park, with an investment forecast of 30 million until 2025. At the commercial level, 3P has developed more than 75 molecules; and with over 60 customers in 20 countries.

3P is aware that the human workforce is the key and differential factor in the success of an international CDMO, one of its main priorities as a company is the recruitment and retention of talent that accompanies the growth and global expansion strategy. With the continuous investment in equipment and technology to meet its customers’ growing demands, some already offer commercial supply of biotechnological drugs.

About 3P Biopharmaceuticals
3P Biopharmaceuticals is a market-leading CDMO (Contract Development and Manufacturing Organization) specializing in process development and GMP (Good Manufacturing Practice) manufacturing of biologics and cell therapy products. 3P offers solutions for all stages related to new drug and biosimilar development and manufacturing including cell line and process development, analytical methods development, pre-clinical and clinical supply and commercial manufacturing.

View the full press release here

Our dedicated team of specialists will be happy to discuss any of your biopharmaceutical needs. Contact us on +34 948 346 480 or email withinus@3pbio.com

Contact of 3P Biopharmaceuticals:
Julie Lecourtois
Communications & Marketing at 3P Biopharmaceuticals
Phone: + 34 948 346 480
email: jlecourtois@3pbio.com

Related Content

3P Biopharmaceuticals and Biosergen complete together the manufacture of biomass for the Mucormycosis “Black Fungus” clinical phase II trial.

3P Biopharmaceuticals has completed the manufacture of BSG005 biomass planned for its client Biosergen. The client also recently announced Phase II clinical trial of BSG005 against Mucormycosis, otherwise known as the Black Fungus.
Read more

Regional Minister Irujo presents the Navarra Health Cluster

This morning, the Regional Minister for Economic and Business Development, Mikel Irujo, presented the Navarra Health Cluster, seeking to position the region as a European benchmark in personalized medicine, one of the priorities of the S4 Smart Specialisation Strategy. The initiative, which stems from the sector's demand and is led by a driving group, is now open to other companies and entities interested in participating.
Read more

3P Biopharmaceuticals awards prize for the best Final Degree Project in Pharmacy at the University of Navarra

3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of biological products, recently awarded the best Final Project Degree (FPD) of Pharmacy. The award forms part of an agreement between 3P and the Faculty of Pharmacy at the University of Navarra promoting digital transformation and professional training within the pharmaceutical industry.
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.